Longitudinal assessment of dementia measures in Down syndrome

Lisa Koehl, Jordan Harp, Kathryn L. Van Pelt, Elizabeth Head, Frederick A. Schmitt

Producción científica: Articlerevisión exhaustiva

18 Citas (Scopus)

Resumen

Introduction: Early detection of dementia symptoms is critical in Down syndrome (DS) but complicated by clinical assessment barriers. The current study aimed to characterize cognitive and behavioral impairment using longitudinal trajectories comparing several measures of cognitive and behavioral functioning. Methods: Measures included global cognitive status (Severe Impairment Battery [SIB]), motor praxis (Brief Praxis Test [BPT]), and clinical dementia informant ratings (Dementia Questionnaire for People with Learning Disabilities [DLD]). One-year reliability was assessed using a two-way mixed effect, consistency, single measurement intraclass correlation among non-demented participants. Longitudinal assessment of SIB, BPT, and DLD was completed using linear mixed effect models. Results: One-year reliability (n = 52; 21 male) was moderate for DLD (0.69 to 0.75) and good for SIB (0.87) and BPT (0.80). Longitudinal analysis (n = 72) revealed significant age by diagnosis interactions for SIB (F(2, 115.02) = 6.06, P =.003), BPT (F(2, 85.59) = 4.56, P =.013), and DLD (F(2, 103.56) = 4.48, P =.014). SIB progression (PR) had a faster decline in performance versus no-dementia (ND) (t(159) = −2.87; P =.013). Dementia had a faster decline in BPT performance versus ND (t(112) = −2.46; P =.041). PR showed quickly progressing scores compared to ND (t(128) = −2.86; P =.014). Discussion: Current measures demonstrated moderate to good reliability. Longitudinal analysis revealed that SIB, BPT, and DLD changed with age depending on diagnostic progression; no change rates were dependent on baseline cognition, indicating usefulness across a variety of severity levels in DS.

Idioma originalEnglish
Número de artículoe12075
PublicaciónAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
Volumen12
N.º1
DOI
EstadoPublished - 2020

Nota bibliográfica

Publisher Copyright:
© 2020 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association

Financiación

informationNational Institute of Child Health and Human Development (HDR01064993); National Institute on Aging (P30 AG028383 & 1T32AG057461).The authors would like to thank Stacey Brothers, Katie McCarty, Roberta Davis, and Amelia Anderson-Mooney, PhD for their assistance with data collection. We also want to thank our team of neurologists—Drs. Gregory Jicha, Donita Lightner, and William Robertson—for their clinical expertise.

FinanciadoresNúmero del financiador
Amelia Anderson-Mooney
National Institute on AgingP30 AG028383, 1T32AG057461
National Institute on Aging
NIH National Institute of Child Health and Human Development National Center for Medical Rehabilitation ResearchHDR01064993
NIH National Institute of Child Health and Human Development National Center for Medical Rehabilitation Research

    ASJC Scopus subject areas

    • Clinical Neurology
    • Psychiatry and Mental health

    Huella

    Profundice en los temas de investigación de 'Longitudinal assessment of dementia measures in Down syndrome'. En conjunto forman una huella única.

    Citar esto